Read More Pharma Industry News What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals New Dupilumab analyses highlight immune modulation claims. Read how Regeneron Pharmaceuticals is testing durability, reimbursement logic, and long-term strategy. bySoujanya RaviFebruary 14, 2026